Ohio Medical Marijuana Control Program Releases Testing Laboratory Provisional License Application Materials

OHIO:The Ohio Medical Marijuana Control Program (MMCP) is scheduled to accept new testing laboratory license applications beginning the week of August 3, 2020. On its testing laboratories webpage, the MMCP has posted two documents for potential applicants to assist in understanding the key substantive attributes of the application.

Potential applicants may submit questions regarding the application materials using instructions listed on the testing laboratories webpage. All questions must be submitted by July 31, 2020. The MMCP will then provide the frequently asked questions and MMCP answers to potential applicants.

For more information, visit the MMCP’s testing laboratories webpage.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For June 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for June 2020. These numbers include:

  • 147,245 Recommendations
  • 116,497 Registered patients
    • 8,349 Patients with Veteran Status
    • 8,713 Patients with Indigent Status
    • 644 Patients with a Terminal Diagnosis
  • 91,330 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 13,140 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For April 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for April 2020. These numbers include:

Ohio Board Of Pharmacy Releases MMJ Patient & Caregiver Numbers For March 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for March 2020. These numbers include:

  • 113,359 Recommendations
  • 94,356 Registered patients
    • 7,031 Patients with Veteran Status
    • 6,990 Patients with Indigent Status
    • 544 Patients with a Terminal Diagnosis
  • 69,585 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 10,790 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Board Of Pharmacy Publishes Updated MMJ Patient & Caregiver Numbers For February 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for February 2020. These numbers include:

  • 102,200 Recommendations
  • 88,306 Registered patients
    • 6,545 Patients with Veteran Status
    • 6,018 Patients with Indigent Status
    • 506 Patients with a Terminal Diagnosis
  • 64,932 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 9,793 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Medical Marijuana Control Program Mandatory Product Recall – 3/13/2020

OHIO: The Ohio Medical Marijuana Control Program (MMCP) is issuing a mandatory product recall on plant material cultivated by Pure Ohio Wellness. This recall is being initiated by the MMCP because product that did not receive the full battery of required testing was sold at dispensaries. The product was not tested for heavy metals, water activity, microbials, mycotoxins, or foreign matter. The MMCP has initiated an investigation into the noncompliance and identified product samples to be tested. These results will be communicated publicly.

AFFECTED PRODUCT:

Product Name: Papaya Punch, Hiker’s Blend, and Tahoe Jack

Purchase Dates: May 10, 2019 – Present

Cultivator Name: Pure Ohio Wellness

Product ID:
• M00000022503: Tier 1 Vap-Hybrid-16.4-.04-Papaya Punch
• M00000022504: Tier 1 Vap-Hybrid-16.9-.07-Hikers Blend
• M00000022506: Tier 1 Vap-Hybrid-18.6-.03-Tahoe Jack
• M00000028027: Tier 1 Vap-Hybrid-14.21-0.05
• M00000032648: Tier 1 Vap-Hybrid-14.48-0.03
• M00000036302: Tier 1 Vap-Sativa-15.50-0
• M00000036303: Tier 1 Vap-Sativa-18.50-0
• M00000036307: Tier 1 Vap-Sativa-14.75-0
• M00000039234: Tier 1 Vap-Sativa-18.50-0 (103) 28.3g
• M00000039235: Tier 1 Vap-Sativa-14.75-0 (104) 8.49g
• M00000039236: Tier 1 Vap-Sativa-14.75-0 (104) 28.3g
• M00000039239: Tier 1 Vap-Sativa-14.75-0 (107) 8.49g
• M00000039240: Tier 1 Vap-Sativa-14.75-0 (107) 28.3g
• M00000039241: Tier 1 Vap-Sativa-15.50-0 (108) 8.49g
• M00000039242: Tier 1 Vap-Sativa-15.50-0 (108) 28.3g

No reports of adverse reactions for this product have been reported to the MMCP at this time.

Patients who have purchased the recalled product should stop using it. All unused product should be returned to the dispensary where purchased. Returned products will not count toward a patient’s 90-day possession limit. For more information on returns, please contact the dispensary where the product was purchased.

Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

Ohio: OMMCP Issues Update On 11.15.19 Medical Marijuana Recall

OHIO: On November 17, 2019, the Ohio Medical Marijuana Control Program (MMCP) issued an updated mandatory product recall for three products (Pineapple Express, Blue Boi Z7, and Afghani #1). The original recall was issued on November 15, 2019.

The Ohio Department of Commerce mandated that samples of the recalled products be submitted for additional laboratory testing, and subsequently found that all products met the required testing standards for patient use.

The MMCP has completed its review of the One Orijin product recall; completing an executive summary which provides an analysis of the circumstances of the recall. The executive summary can be found here.

The full updated recall notice can be found here.

Ohio Medical Marijuana Advisory Committee March 2020 Meeting Notice

OMMCP

OHIO: The Medical Marijuana Advisory Committee will hold a meeting on March 5, 2020.

ADVISORY COMMITTEE

The Medical Marijuana Advisory Committee is coordinated by the Board of Pharmacy. The Committee may develop and submit to the Department of Commerce, State Board of Pharmacy, and the State Medical Board any recommendations related to the Medical Marijuana Control Program and the implementation and enforcement of the related Ohio Revised Code. Its membership includes the following:

  • Megan E. Marchal, Pharm.D., (Chair), practicing pharmacist and member of the State of Ohio Board of Pharmacy.
  • Stephanie M. Abel, Pharm.D., practicing pharmacist.
  • Tony E. Coder, Jr., representing persons involved in the treatment of drug and alcohol addiction.
  • Michael G. Hirsch, representing agriculture.
  • Sheriff John Lenhart, representing local law enforcement.
  • Jason Kaseman, representing labor.
  • Megan Lawrence, representing caregivers.
  • Dr. Jerry W. Mitchell, Jr., practicing physician.
  • Nancy Walsh Mosca, CNP, practicing nurse.
  • Marcie Seidel, representing persons involved in mental health treatment.
  • Dr. Amol Soin, practicing physician and member of the State Medical Board of Ohio.
  • Michael E. Stanek, representing employers.
  • Gary L. Wenk, engages in academic research.
  • Christopher Stock, representing patients.

Ohio Board Of Pharmacy Awards Third Dispensary Certificate Of Operation In Newark

State_of_Ohio_Board_of_pharmacy_logo2C

 

OHIO: The State of Ohio Board of Pharmacy today awarded a Dispensary Certificate of Operation to Herbology, located at 1150 N. 21st St., Newark.

The Board has now issued 50 Dispensary Certificates of Operation.

The interactive map of Dispensaries with Certificates of Operation will be updated within two business days.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For January 2020

State_of_Ohio_Board_of_pharmacy_logo2C

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for January 2020.

These numbers include:

  • 94,771 Recommendations
  • 84,023 Registered patients
    • 6,163 Patients with Veteran Status
    • 5,382 Patients with Indigent Status
    • 473 Patients with a Terminal Diagnosis
  • 60,260 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 9,153 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.